BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18426852)

  • 1. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study.
    Freeman K; Tan HK; Prusa A; Petersen E; Buffolano W; Malm G; Cortina-Borja M; Gilbert R;
    Pediatrics; 2008 May; 121(5):e1215-22. PubMed ID: 18426852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Ocular Outcomes in Congenital Toxoplasmosis Treated Perinatally.
    Journé A; Garweg J; Ksiazek E; Peyron F; Binquet C; Wallon M
    Pediatrics; 2024 Apr; 153(4):. PubMed ID: 38454832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular manifestations in congenital toxoplasmosis.
    Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term ocular prognosis in 327 children with congenital toxoplasmosis.
    Wallon M; Kodjikian L; Binquet C; Garweg J; Fleury J; Quantin C; Peyron F
    Pediatrics; 2004 Jun; 113(6):1567-72. PubMed ID: 15173475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
    Gras L; Gilbert RE; Ades AE; Dunn DT
    Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.
    Gilbert RE; Freeman K; Lago EG; Bahia-Oliveira LM; Tan HK; Wallon M; Buffolano W; Stanford MR; Petersen E;
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e277. PubMed ID: 18698419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
    Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
    Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe ocular sequelae of congenital toxoplasmosis: huge macular scar.
    Zahir F; Abdellaoui M; Younes S; Benatiya IA; Tahri H
    Pan Afr Med J; 2015; 20():233. PubMed ID: 27386029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
    Kuchar A; Hayde M; Steinkogler FJ
    Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of pregnant women and children treated at a reference center for congenital toxoplasmosis in the northern state of Minas Gerais, Brazil.
    Soares JA; Carvalho SF; Caldeira AP
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):55-9. PubMed ID: 22370829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.
    Wallon M; Garweg JG; Abrahamowicz M; Cornu C; Vinault S; Quantin C; Bonithon-Kopp C; Picot S; Peyron F; Binquet C
    Pediatrics; 2014 Mar; 133(3):e601-8. PubMed ID: 24534412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis.
    Tan HK; Schmidt D; Stanford M; Teär-Fahnehjelm K; Ferret N; Salt A; Gilbert R;
    Am J Ophthalmol; 2007 Nov; 144(5):648-653. PubMed ID: 17854757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early diagnosis and treatment of chorioretinitis in children with congenital toxoplasmosis].
    Gerkowicz K
    Klin Oczna; 1979; 81(2):135-7. PubMed ID: 439718
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
    ; Thiébaut R; Leproust S; Chêne G; Gilbert R
    Lancet; 2007 Jan; 369(9556):115-22. PubMed ID: 17223474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
    Gras L; Wallon M; Pollak A; Cortina-Borja M; Evengard B; Hayde M; Petersen E; Gilbert R;
    Acta Paediatr; 2005 Dec; 94(12):1721-31. PubMed ID: 16421031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Outcome of Brazilian Patients With Congenital Toxoplasmosis.
    Lago EG; Endres MM; Scheeren MFDC; Fiori HH
    Pediatr Infect Dis J; 2021 Jan; 40(1):e21-e27. PubMed ID: 33060522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
    O'Neill JF
    Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of systematic ophthalmological screening for congenital toxoplasmosis: epidemiological study of an Alsatian cohort from 1990 to 2011].
    Subilia-Guignier A; Villard O; Filisetti D; Escande B; Candolfi E; Speeg-Schatz C; Sauer A
    J Fr Ophtalmol; 2014 May; 37(5):365-70. PubMed ID: 24698638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK survey.
    Stanford MR; Tan HK; Gilbert RE
    Br J Ophthalmol; 2006 Dec; 90(12):1464-7. PubMed ID: 16899532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.